Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Via E. Orabona 4, 70126 Bari, Italy.
J Bioenerg Biomembr. 2013 Aug;45(4):369-81. doi: 10.1007/s10863-013-9513-0. Epub 2013 Apr 26.
Amyloid beta peptide (AβP) is a natural peptide, normally released into the cerebrospinal fluid (CSF), that plays a key role in Alzheimer's disease. The conversion of the peptide from a native soluble form to a non-native and often insoluble form, such as small and large aggregates, protofibrils and fibrils of AβP appears to be implicated in the pathogenesis of AD. Although the molecular mechanisms of AβP neurotoxicity are not fully understood, a large body of data suggests that the primary target of amyloid peptides is the cell membrane of neurons, that may modulate the structural and functional conversion of AβP into assemblies involved in pathological processes. In our study, we provide a systematic investigation of AβP1-42's ability to incorporate and form channel-like events in membranes of different lipid composition and focus on cholesterol and its oxidation products. We propose that cholesterol and its oxidation products can be considered neuroprotective factors because a) by favouring AβP1-42 insertion into membranes, the fibrillation/clearance balance shifts toward clearance; b) by shifting channel selectivity toward anions, the membrane potential is moved far from the threshold of membrane excitability, thus decreasing the influx of calcium into the cell.
淀粉样β肽(AβP)是一种天然肽,通常释放到脑脊液(CSF)中,在阿尔茨海默病中起关键作用。肽从天然可溶性形式向非天然且通常不溶性形式(如 AβP 的小和大聚集体、原纤维和纤维)的转化似乎与 AD 的发病机制有关。尽管 AβP 神经毒性的分子机制尚未完全阐明,但大量数据表明,淀粉样肽的主要靶标是神经元的细胞膜,这可能调节 AβP 结构和功能的转化为参与病理过程的组装。在我们的研究中,我们系统地研究了 AβP1-42 整合到不同脂质组成的膜中和形成通道样事件的能力,并重点研究了胆固醇及其氧化产物。我们提出,胆固醇及其氧化产物可以被认为是神经保护因子,因为 a)通过促进 AβP1-42 插入膜中,纤维/清除平衡向清除方向移动;b)通过将通道选择性转移到阴离子,膜电位远离膜兴奋性的阈值移动,从而减少钙进入细胞。